Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25,847 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combinative workflow for mRNA vaccine development.
Khanzode R, Soni G, Srivastava S, Pawar S, Wadapurkar R, Singh A. Khanzode R, et al. Among authors: singh a. Biochem Biophys Rep. 2024 Jun 28;39:101766. doi: 10.1016/j.bbrep.2024.101766. eCollection 2024 Sep. Biochem Biophys Rep. 2024. PMID: 39040540 Free PMC article.
Augmenting the landscape of chimeric antigen receptor T-cell therapy.
Srivastava S, Singh S, Singh A. Srivastava S, et al. Among authors: singh s, singh a. Expert Rev Anticancer Ther. 2024 Aug;24(8):755-773. doi: 10.1080/14737140.2024.2372330. Epub 2024 Jun 26. Expert Rev Anticancer Ther. 2024. PMID: 38912754 Review.
An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial.
Saraf A, Gurjar R, Kaviraj S, Kulkarni A, Kumar D, Kulkarni R, Virkar R, Krishnan J, Yadav A, Baranwal E, Singh A, Raghuwanshi A, Agarwal P, Savergave L, Singh S; GEMCOVAC-OM Study Investigators. Saraf A, et al. Among authors: singh s, singh a. Nat Med. 2024 May;30(5):1363-1372. doi: 10.1038/s41591-024-02955-2. Epub 2024 Apr 18. Nat Med. 2024. PMID: 38637636 Free PMC article. Clinical Trial.
Acquisition of discrete immune suppressive barriers contributes to the initiation and progression of preinvasive to invasive human lung cancer.
Yoffe L, Bhinder B, Kang SW, Zhang H, Singh A, Ravichandran H, Markowitz G, Martin M, Kim J, Zhang C, Elemento O, Tansey W, Bates S, McGraw TE, Borczuk A, Lee HS, Altorki NK, Mittal V. Yoffe L, et al. Among authors: singh a. bioRxiv [Preprint]. 2025 Jan 1:2024.12.31.630523. doi: 10.1101/2024.12.31.630523. bioRxiv. 2025. PMID: 39803458 Free PMC article. Preprint.
Transient glycan-shield reduction induces CD4-binding site broadly neutralizing antibodies in SHIV-infected macaques.
Morris DJ, Gorman J, Zhou T, Lora J, Connell AJ, Li H, Liu W, Roark RS, Campion MS, Carey JW, Habib R, Li Y, Martella CL, Park Y, Singh A, Sowers KJ, Teng IT, Wang S, Chohan N, Ding W, Lauer C, Lewis E, Mason RD, Rando JM, Peyton L, Schramm CA, Wagh K, Korber B, Seaman MS, Douek DC, Haynes BF, Kulp DW, Roederer M, Hahn BH, Kwong PD, Shaw GM. Morris DJ, et al. Among authors: singh a. bioRxiv [Preprint]. 2024 Dec 30:2024.12.30.630768. doi: 10.1101/2024.12.30.630768. bioRxiv. 2024. PMID: 39803442 Free PMC article. Preprint.
25,847 results
You have reached the last available page of results. Please see the User Guide for more information.